Orca Biosystems, Inc.
Clinical trials sponsored by Orca Biosystems, Inc., explained in plain language.
-
New cell therapy aims to improve transplant outcomes for leukemia patients
Disease control Recruiting nowThis study tests a new treatment called Orca-T for people with acute myeloid leukemia or myelodysplastic syndrome. Orca-T is made from a donor's blood cells and is given after a gentle chemotherapy or radiation preparation. The goal is to see if it helps the body accept the trans…
Phase: PHASE2 • Sponsor: Orca Biosystems, Inc. • Aim: Disease control
Last updated May 26, 2026 10:48 UTC
-
Engineered donor cells aim to make stem cell transplants safer for blood cancer patients
Disease control Recruiting nowThis early-phase study is testing a new way to prepare donor stem cells, called Orca-Q, for people with certain blood cancers (like leukemia) who need a stem cell transplant. The goal is to see if this engineered graft is safe and helps the body accept the new cells without sever…
Phase: PHASE1 • Sponsor: Orca Biosystems, Inc. • Aim: Disease control
Last updated May 26, 2026 10:47 UTC